Ocumension Therapeutics
HKEX:1477.HK
5.43 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 71.336 | 71.336 | 51.848 | 51.848 | 52.211 | 52.211 | 27.268 | 27.268 | 17.672 | 17.672 | 10.402 | 10.402 | 5.572 | 5.572 | 0.976 | 0.976 | 0.095 | 0.095 | 0 | 0 |
| Cost of Revenue
| 30.508 | 30.508 | 20.493 | 20.493 | 17.905 | 17.905 | 10.116 | 10.116 | 7.048 | 7.048 | 2.558 | 2.558 | 0.851 | 0.851 | 0.011 | 0.011 | 0.005 | 0.005 | 0 | 0 |
| Gross Profit
| 40.828 | 40.828 | 31.355 | 31.355 | 34.306 | 34.306 | 17.152 | 17.152 | 10.624 | 10.624 | 7.844 | 7.844 | 4.721 | 4.721 | 0.965 | 0.965 | 0.09 | 0.09 | 0 | 0 |
| Gross Profit Ratio
| 0.572 | 0.572 | 0.605 | 0.605 | 0.657 | 0.657 | 0.629 | 0.629 | 0.601 | 0.601 | 0.754 | 0.754 | 0.847 | 0.847 | 0.989 | 0.989 | 0.947 | 0.947 | 0 | 0 |
| Reseach & Development Expenses
| 25.339 | 25.339 | 36.546 | 36.546 | 42.935 | 42.935 | 49.22 | 49.22 | 38.406 | 38.406 | 46.122 | 46.122 | 63.721 | 63.721 | 26.055 | 26.055 | 34.351 | 34.351 | 15.381 | 15.381 |
| General & Administrative Expenses
| 48.291 | 48.291 | 49.781 | 49.781 | 57.675 | 57.675 | 37.699 | 37.699 | 34.051 | 34.051 | 29.029 | 29.029 | 41.072 | 41.072 | 75.334 | 75.334 | 15.016 | 15.016 | 13.577 | 13.577 |
| Selling & Marketing Expenses
| 55.797 | 55.797 | 57.33 | 57.33 | 52.172 | 52.172 | 39.348 | 39.348 | 41.268 | 41.268 | 22.556 | 22.556 | 17.152 | 17.152 | 8.213 | 8.213 | 1.24 | 1.24 | 0 | 0 |
| SG&A
| 104.128 | 104.128 | 107.245 | 107.245 | 110.047 | 110.047 | 77.189 | 77.189 | 75.319 | 75.319 | 51.585 | 51.585 | 58.224 | 58.224 | 83.547 | 83.547 | 16.255 | 16.255 | 13.577 | 13.577 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 130.692 | 130.692 | 141.528 | 141.528 | 145.934 | 145.934 | 119.852 | 119.852 | 113.001 | 113.001 | 48.622 | 48.622 | 273.377 | 273.377 | 875.865 | 875.865 | 540.782 | 540.782 | 123.956 | 123.956 |
| Operating Income
| -88.639 | -88.639 | -112.435 | -112.435 | -118.676 | -118.676 | -109.256 | -109.256 | -103.1 | -103.1 | -89.863 | -89.863 | -117.223 | -117.223 | -108.636 | -108.636 | -50.516 | -50.516 | -28.958 | -28.958 |
| Operating Income Ratio
| -1.243 | -1.243 | -2.169 | -2.169 | -2.273 | -2.273 | -4.007 | -4.007 | -5.834 | -5.834 | -8.639 | -8.639 | -21.038 | -21.038 | -111.307 | -111.307 | -531.747 | -531.747 | 0 | 0 |
| Total Other Income Expenses Net
| 3.03 | 3.03 | 8.304 | 8.304 | 13.715 | 13.715 | 13.103 | 13.103 | 7.909 | 7.909 | 55.059 | 55.059 | -144.325 | -144.325 | -762.249 | -762.249 | -488.255 | -488.255 | -95.012 | -95.012 |
| Income Before Tax
| -85.609 | -85.609 | -104.132 | -104.132 | -104.961 | -104.961 | -96.154 | -96.154 | -95.192 | -95.192 | -34.805 | -34.805 | -261.548 | -261.548 | -870.885 | -870.885 | -538.771 | -538.771 | -123.97 | -123.97 |
| Income Before Tax Ratio
| -1.2 | -1.2 | -2.008 | -2.008 | -2.01 | -2.01 | -3.526 | -3.526 | -5.387 | -5.387 | -3.346 | -3.346 | -46.94 | -46.94 | -892.3 | -892.3 | -5,671.274 | -5,671.274 | 0 | 0 |
| Income Tax Expense
| 0.084 | 0.084 | 0.07 | 0.07 | 0.026 | 0.026 | 0.181 | 0.181 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.6 | -1.6 | -4.986 | -4.986 |
| Net Income
| -85.693 | -85.693 | -104.201 | -104.201 | -104.987 | -104.987 | -96.335 | -96.335 | -95.192 | -95.192 | -34.805 | -34.805 | -261.548 | -261.548 | -870.885 | -870.885 | -537.172 | -537.172 | -118.984 | -118.984 |
| Net Income Ratio
| -1.201 | -1.201 | -2.01 | -2.01 | -2.011 | -2.011 | -3.533 | -3.533 | -5.387 | -5.387 | -3.346 | -3.346 | -46.94 | -46.94 | -892.3 | -892.3 | -5,654.437 | -5,654.437 | 0 | 0 |
| EPS
| -0.13 | -0.13 | -0.16 | -0.16 | -0.16 | -0.16 | -0.15 | -0.15 | -0.15 | -0.15 | -0.058 | -0.058 | -0.48 | -0.48 | -13.68 | -13.68 | -10.75 | -10.75 | -3.71 | -3.71 |
| EPS Diluted
| -0.13 | -0.13 | -0.16 | -0.16 | -0.16 | -0.16 | -0.15 | -0.15 | -0.15 | -0.15 | -0.058 | -0.058 | -0.48 | -0.48 | -13.68 | -13.68 | -10.75 | -10.75 | -3.71 | -3.71 |
| EBITDA
| -77.159 | -77.159 | -100.722 | -100.722 | -110.793 | -110.793 | -103.59 | -103.59 | -99.354 | -99.354 | -88.801 | -88.801 | -116.283 | -116.283 | -108.025 | -108.025 | -50.424 | -50.424 | -28.925 | -28.925 |
| EBITDA Ratio
| -1.082 | -1.082 | -1.943 | -1.943 | -2.122 | -2.122 | -3.799 | -3.799 | -5.622 | -5.622 | -8.537 | -8.537 | -20.869 | -20.869 | -110.681 | -110.681 | -530.779 | -530.779 | 0 | 0 |